PHARMACEUTICAL CONTRACT MANUFACTURING

Day 1: 8th September 2026, London, United Kingdom

Optimizing Pharmaceutical Outsourcing Through Strategic CMOs, Innovation Scaling, Supply Chain Resilience, and Advanced Manufacturing Technologies Adoption

Agenda - Day Two
Agenda - Day Two

PANEL DISCUSSION ON TECHNOLOGY TRANSFER

09:00 Managing Technology Transfer Complexity In Sponsor And Contract Manufacturing Partnerships

This panel explores how technology transfer between sponsors and Contract Manufacturing Organizations (CMOs) is a high-stakes process that goes beyond documentation. Success relies on deep process understanding, cross-functional alignment, and effective knowledge sharing, while misalignment can drive delays, deviations, and added costs. Digital tools and standardized protocols help streamline transfers and reduce variability, and early CMO involvement improves efficiency and robustness. Targeted training builds understanding of critical process parameters and quality attributes, while transparent, continuous communication across stakeholders ensures smooth, reliable execution.

Discussion Topics:

  • Managing Complexity in Technology Transfer Between Sponsors and Contract Manufacturing Organizations

  • Strengthening Sponsor and CMO Collaboration to Improve Technology Transfer Success and Reliability

  • Digital Enablement of Technology Transfer: Standardization, Scalability, and Control Across CMOs

  • Early CMO Engagement as a Lever for Robust and Efficient Process Transfer

10:30 Optimizing pharmaceutical contract manufacturing innovation through coordinated development and production alliances

This talk examines how pharmaceutical contract manufacturing supports scalable innovation through strategic partnerships spanning development and production. By combining specialized expertise, flexible capacity, and robust regulatory compliance, these collaborations speed up time to market, reduce costs, and maintain high quality standards, enabling innovators to focus on research while experienced partners handle complex manufacturing and supply chain operations.

10:55 Questions & Discussion

11:00 Morning Break

PANEL DISCUSSION ON SUPPLY CHAIN MANAGEMENT

11:30 Explores Strategic Role Of Contract Manufacturing Organizations In Global Pharmaceutical Supply Chains

This presentation critically examines how Contract Manufacturing Organizations (CMOs) play a key strategic role in modern pharmaceutical supply chains by enabling scalability, flexibility, and efficiency. They allow pharmaceutical companies to respond quickly to fluctuating demand without major capital investment, freeing resources for core activities such as research and development. CMOs also speed up time-to-market through established infrastructure and regulatory expertise. As global supply chains grow more complex, resilient operations increasingly rely on diversified and reliable manufacturing partnerships. Effective risk mitigation involves multi-sourcing and geographic distribution. Ultimately, strong strategic alignment between sponsors and CMOs is essential to ensure quality, continuity, and long-term collaborative success.

Discussion Topics:

  • Leveraging Contract Manufacturing Organizations (CMOs) to Achieve Scalable and Flexible Capacity in Fluctuating Pharmaceutical Demand

  • Examining Outsourcing as a Lever for Capital Expenditure Optimization and Core Competency Concentration in R&D

  • Analyzing Global Supply Chain Resilience Through Reliable And Diversified Contract Manufacturing Partnerships

  • Risk Mitigation Strategies Multi Sourcing and Geographic Diversification of Manufacturing Partners

  • Achieving collaboration success via strategic alignment between sponsors and CMOs

13:00 Lunch Break

14:00 Evaluation of Digital Transformation and Industry 4.0 Adoption in Pharmaceutical Contract Manufacturing

This talk explores how digital transformation and Industry 4.0 adoption in pharmaceutical contract manufacturing can enhance operational efficiency through digital technologies and data-driven decision-making. Predictive maintenance helps reduce downtime, while real-time analytics improves quality control and enables process optimisation. Digital twins and simulation tools support better design, validation, and operational planning. However, key challenges remain, including high implementation costs, the need for workforce upskilling, cybersecurity risks related to protecting sensitive manufacturing data and systems, and strict regulatory compliance requirements.

14:25 Questions & Discussion

14:30 Cost Optimization Versus Quality Maintenance in Pharmaceutical Contract Manufacturing Partnerships

The session focuses on the challenge of balancing cost optimization with quality maintenance in pharmaceutical contract manufacturing partnerships.

It highlights how transparent pricing, lean manufacturing, and process optimization can reduce waste while preserving compliance, safety, and product integrity. Long-term collaborations and investment in automation and innovation improve cost predictability and drive sustained efficiency gains without compromising quality standards across supply chain.

14:55 Questions & Discussion

15:00 Afternoon Break

PANEL DISCUSSION ON VENDOR EVALUATION

15:30 Vendor Selection Criteria and Evaluation Strategies for Contract Manufacturing Organizations

This discussion explores structured approaches to selecting and managing Contract Manufacturing Organizations (CMOs). It highlights key criteria such as technical expertise, regulatory compliance, and financial health, alongside the importance of audits and due diligence. Emphasis is placed on cultural alignment, communication, and performance metrics, while considering geographic factors and long-term compatibility to ensure reliable, efficient, and sustainable outsourcing partnerships.

Discussion Topics:

  • Evaluation of selection criteria includes technical capabilities, compliance history, and financial stability assessment.

  • Reviewing site audits alongside due diligence activities ensures consistent alignment with applicable quality and regulatory requirements.

  • Investigating cultural fit and communication effectiveness provides insight into factors driving partnership success.

  • Analysing performance metrics enables better understanding of vendor reliability while tracking efficiency across long-term service delivery.

  • Evaluating how sustained compatibility between parties influences long-term success in outsourcing relationships.

17:00 End of day 1